Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LEAP THERAPEUTICS, INC. | Chief Scientific Officer | Employee Stock Option (Right to Buy) | 85K | Oct 2, 2024 | Direct | ||
LEAP THERAPEUTICS, INC. | Chief Scientific Officer | Employee Stock Option (Right to Buy) | 85K | Jan 29, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LPTX | LEAP THERAPEUTICS, INC. | Oct 2, 2024 | 1 | $0 | 4 | Oct 4, 2024 | Chief Scientific Officer |
LPTX | LEAP THERAPEUTICS, INC. | Jan 29, 2024 | 1 | $0 | 4 | Jan 31, 2024 | Chief Scientific Officer |
LPTX | LEAP THERAPEUTICS, INC. | Aug 23, 2023 | 1 | $0 | 4 | Aug 25, 2023 | Chief Scientific Officer |
LPTX | LEAP THERAPEUTICS, INC. | Apr 1, 2023 | 0 | $0 | 3 | Apr 3, 2023 | Chief Scientific Officer |